Literature DB >> 8643630

A functional peptide encoded in the Escherichia coli 23S rRNA.

T Tenson1, A DeBlasio, A Mankin.   

Abstract

A pentapeptide open reading frame equipped with a canonical ribosome-binding site is present in the Escherichia coli 23S rRNA. Overexpression of 23S rRNA fragments containing the mini-gene renders cells resistant to the ribosome-inhibiting antibiotic erythromycin. Mutations that change either the initiator or stop codons of the peptide mini-gene result in the loss of erythromycin resistance. Nonsense mutations in the mini-gene also abolish erythromycin resistance, which can be restored in the presence of the suppressor tRNA, thus proving that expression of the rRNA-encoded peptide is essential for the resistance phenotype. The ribosome appears to be the likely target of action of the rRNA-encoded pentapeptide, because in vitro translation of the peptide mini-gene decreases the inhibitory action of erythromycin on cell-free protein synthesis. Thus, the new mechanism of drug resistance reveals that in addition to the structural and functional role of rRNA in the ribosome, it may also have a peptide-coding function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643630      PMCID: PMC39301          DOI: 10.1073/pnas.93.11.5641

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Mapping of suppressor loci in Escherichia coli.

Authors:  E R Signer; J R Beckwith; S Brenner
Journal:  J Mol Biol       Date:  1965-11       Impact factor: 5.469

2.  Evidence for functional interaction between domains II and V of 23S ribosomal RNA from an erythromycin-resistant mutant.

Authors:  S Douthwaite; J B Prince; H F Noller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli.

Authors:  C D Sigmund; M Ettayebi; E A Morgan
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

4.  Secondary structure model for 23S ribosomal RNA.

Authors:  H F Noller; J Kop; V Wheaton; J Brosius; R R Gutell; A M Kopylov; F Dohme; W Herr; D A Stahl; R Gupta; C R Waese
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

5.  Gene organization and primary structure of a ribosomal RNA operon from Escherichia coli.

Authors:  J Brosius; T J Dull; D D Sleeter; H F Noller
Journal:  J Mol Biol       Date:  1981-05-15       Impact factor: 5.469

6.  Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics.

Authors:  R Skinner; E Cundliffe; F J Schmidt
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

7.  The tac promoter: a functional hybrid derived from the trp and lac promoters.

Authors:  H A de Boer; L J Comstock; M Vasser
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli.

Authors:  C D Sigmund; E A Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.

Authors:  J Shine; L Dalgarno
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  In vivo translation of a region within the rrnB 16S rRNA gene of Escherichia coli.

Authors:  K L Berg; C L Squires; C Squires
Journal:  J Bacteriol       Date:  1987-04       Impact factor: 3.490

View more
  27 in total

1.  Suppression of nonsense mutations induced by expression of an RNA complementary to a conserved segment of 23S rRNA.

Authors:  N S Chernyaeva; E J Murgola; A S Mankin
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Selecting rRNA binding sites for the ribosomal proteins L4 and L6 from randomly fragmented rRNA: application of a method called SERF.

Authors:  U Stelzl; C M Spahn; K H Nierhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Enod40, a short open reading frame-containing mRNA, induces cytoplasmic localization of a nuclear RNA binding protein in Medicago truncatula.

Authors:  Anna Campalans; Adam Kondorosi; Martin Crespi
Journal:  Plant Cell       Date:  2004-03-22       Impact factor: 11.277

4.  Inhibition of translation and cell growth by minigene expression.

Authors:  T Tenson; J V Herrera; P Kloss; G Guarneros; A S Mankin
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

Review 5.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

6.  Transient erythromycin resistance phenotype associated with peptidyl-tRNA drop-off on early UGG and GGG codons.

Authors:  Mirjana Macvanin; Ernesto I Gonzalez de Valdivia; David H Ardell; Leif A Isaksson
Journal:  J Bacteriol       Date:  2007-10-19       Impact factor: 3.490

Review 7.  Inhibition of bacterial ribosome assembly: a suitable drug target?

Authors:  Bruce A Maguire
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

8.  Novel long non-protein coding RNAs involved in Arabidopsis differentiation and stress responses.

Authors:  Besma Ben Amor; Sonia Wirth; Francisco Merchan; Philippe Laporte; Yves d'Aubenton-Carafa; Judith Hirsch; Alexis Maizel; Allison Mallory; Antoine Lucas; Jean Marc Deragon; Herve Vaucheret; Claude Thermes; Martin Crespi
Journal:  Genome Res       Date:  2008-11-07       Impact factor: 9.043

Review 9.  Macrolide myths.

Authors:  Alexander S Mankin
Journal:  Curr Opin Microbiol       Date:  2008-10-03       Impact factor: 7.934

Review 10.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.